- Isolated Tumor Cells in Regional Lymph Nodes as Relapse Predictors in Stage I and II Colorectal Cancer
[作者:Mescoli, C; Albertoni, L; Pucciarelli, S; Giacomelli, L; Russo, VM; Fassan, M; Nitti, D; Rugge, M,期刊:Journal of clinical oncology, 页码:965-971 , 文章类型: Article,,卷期:2012年30-9]
- Purpose Lymph node (LN) involvement is the most important prognostic factor in colorectal cancer (CRC), and pN-positive status identifies patients who require adjuvant chemotherapy. Approximately 15% to 20% of patients w...
- Long-Term Follow-Up of Children Treated for High-Grade Gliomas: Children's Oncology Group L991 Final Study Report
[作者:Sands, SA; Zhou, TN; O'Neil, SH; Patel, SK; Allen, J; Cullen, PM; Kaleita, TA; Noll, R; Sklar, C; Finlay, JL,期刊:Journal of clinical oncology, 页码:943-949 , 文章类型: Article,,卷期:2012年30-9]
- Purpose High-grade gliomas of the CNS are characterized by poor treatment response and prognosis for long-term survival. The Children's Oncology Group (COG) L991 study investigated the neuropsychological, behavioral, and...
- Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
[作者:von Tresckow, B; Plutschow, A; Fuchs, M; Klimm, B; Markova, J; Lohri, A; Kral, Z; Greil, R; Topp, MS; Meissner, J; Zijlstra, JM; Soekler, M; Stein, H; Eich, HT; Mueller, RP; Diehl, V; Borchmann, P; Engert, A,期刊:Journal of clinical oncology, 页码:907-913 , 文章类型: Article,,卷期:2012年30-9]
- Purpose In patients with early unfavorable Hodgkin's lymphoma (HL), combined modality treatment with four cycles of ABVD (adriamycin, bleomycin, vinblastine, and dacarbazine) and 30 Gy involved-field radiotherapy (IFRT) ...
- Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer
[作者:Chagpar, R; Xing, Y; Chiang, YJ; Feig, BW; Chang, GJ; You, YN; Cormier, JN,期刊:Journal of clinical oncology, 页码:972-979 , 文章类型: Article,,卷期:2012年30-9]
- Purpose Adherence to evidence-based treatment guidelines has been proposed as a measure of cancer care quality. We sought to determine rates of and factors associated with adherence to the National Comprehensive Cancer N...
- Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial
[作者:Bottcher, S; Ritgen, M; Fischer, K; Stilgenbauer, S; Busch, RM; Fingerle-Rowson, G; Fink, AM; Buhler, A; Zenz, T; Wenger, MK; Mendila, M; Wendtner, CM; Eichhorst, BF; Dohner, H; Hallek, MJ; Kneba, M,期刊:Journal of clinical oncology, 页码:980-988 , 文章类型: Article,,卷期:2012年30-9]
- Purpose To determine the clinical significance of flow cytometric minimal residual disease (MRD) quantification in chronic lymphocytic leukemia (CLL) in addition to pretherapeutic risk factors and to compare the prognost...
- First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
[作者:Bergh, J; Bondarenko, IM; Lichinitser, MR; Liljegren, A; Greil, R; Voytko, NL; Makhson, AN; Cortes, J; Lortholary, A; Bischoff, J; Chan, A; Delaloge, S; Huang, X; Kern, KA; Giorgetti, C,期刊:Journal of clinical oncology, 页码:921-929 , 文章类型: Article,,卷期:2012年30-9]
- Purpose To investigate whether sunitinib plus docetaxel improves clinical outcomes for patients with human epidermal growth factor receptor 2 (HER2)/neu-negative advanced breast cancer (ABC) versus docetaxel alone. Patie...
|